Rxwire
In the news · 48h FDA 37 Eli Lilly 20 Roche 11 Merck & Co. (MSD) 9 Johnson & Johnson 5 Daiichi Sankyo 3 AstraZeneca 3 Novo Nordisk 3
Approvals & regulatory · first seen 1h ago, updated 1h ago

MHRA approves Pharma Mar’s lurbinectedin for extensive-stage small cell lung cancer

1 outlet

The treatment is for adults in combination with atezolizumab

Summary from PMLiVE.

Coverage 1 article · 1 outlet

  1. PMLiVE
    MHRA approves Pharma Mar’s lurbinectedin for extensive-stage small cell lung cancer